Novartis
Novartis Breast Cancer Drug Fast-Tracked by FDA
By HelpRx Staff Writer on November 17, 2016
Ribociclib, a new experimental breast cancer drug from manufacturer Novartis, has received fast-track review status from ... Continue Reading >
Our cardholders have saved
$1,000,000,000